OT-II mice were immunized with OVA peptide-pulsed WT BMDCs, WT CurDCs or dectin-1−/− CurDCs at days 3 and 10 after challenge with B16-OVA melanoma cells. The gene discussed is CLEC7A; the disease is melanoma.